These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9472961)

  • 1. The actions of a novel lipoprotein lipase activator, NO-1886, in hypertriglyceridemic fructose-fed rats.
    Hara T; Cameron-Smith D; Cooney GJ; Kusunoki M; Tsutsumi K; Storlien LH
    Metabolism; 1998 Feb; 47(2):149-53. PubMed ID: 9472961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886.
    Kusunoki M; Tsutsumi K; Hara T; Ogawa H; Nakamura T; Miyata T; Sakakibara F; Fukuzawa Y; Suga T; Kakumu S; Nakaya Y
    Metabolism; 2002 Jun; 51(6):792-5. PubMed ID: 12037738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886.
    Kusunoki M; Tsutsumi K; Sato D; Nakamura A; Habu S; Mori Y; Morishita M; Yonemoto T; Miyata T; Nakaya Y; Nakamura T
    Eur J Pharmacol; 2011 Oct; 668(3):486-91. PubMed ID: 21835171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NO-1886 (ibrolipim), a lipoprotein lipase activator, increases the expression of uncoupling protein 3 in skeletal muscle and suppresses fat accumulation in high-fat diet-induced obesity in rats.
    Kusunoki M; Tsutsumi K; Iwata K; Yin W; Nakamura T; Ogawa H; Nomura T; Mizutani K; Futenma A; Utsumi K; Miyata T
    Metabolism; 2005 Dec; 54(12):1587-92. PubMed ID: 16311090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the K+ channel opener KRN4884 on the cardiovascular metabolic syndrome model in rats.
    Okada Y; Yoshino T; Takeuchi A; Endoh M; Ohta H; Jinno Y; Yokoyama T; Izawa T; Kobayshi E
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):287-93. PubMed ID: 10672863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet.
    Kusunoki M; Hara T; Tsutsumi K; Nakamura T; Miyata T; Sakakibara F; Sakamoto S; Ogawa H; Nakaya Y; Storlien LH
    Diabetologia; 2000 Jul; 43(7):875-80. PubMed ID: 10952460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Masoprocol decreases serum triglyceride concentrations in rats with fructose-induced hypertriglyceridemia.
    Scribner KA; Gadbois TM; Gowri M; Azhar S; Reaven GM
    Metabolism; 2000 Sep; 49(9):1106-10. PubMed ID: 11016888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term metabolic and haemodynamic effects of GR79236 in normal and fructose-fed rats.
    Qu X; Cooney G; Donnelly R
    Eur J Pharmacol; 1997 Nov; 338(3):269-76. PubMed ID: 9424021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial characterization of the fructose-induced defect in very-low-density lipoprotein triglyceride metabolism.
    Mamo JC; Hirano T; James L; Szeto L; Steiner G
    Metabolism; 1991 Sep; 40(9):888-93. PubMed ID: 1895953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligofructose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats.
    Busserolles J; Gueux E; Rock E; Demigné C; Mazur A; Rayssiguier Y
    J Nutr; 2003 Jun; 133(6):1903-8. PubMed ID: 12771337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
    Kazumi T; Hirano T; Odaka H; Ebara T; Amano N; Hozumi T; Ishida Y; Yoshino G
    Diabetes; 1996 Jun; 45(6):806-11. PubMed ID: 8635657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity.
    Mangaloglu L; Cheung RC; Van Iderstine SC; Taghibiglou C; Pontrelli L; Adeli K
    Metabolism; 2002 Apr; 51(4):409-18. PubMed ID: 11912545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary rat models in which the development of hypertriglyceridemia and that of insulin resistance are dissociated.
    Boivin A; Deshaies Y
    Metabolism; 1995 Dec; 44(12):1540-7. PubMed ID: 8786721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of adipose tissue lipoprotein lipase to insulin action in rats fed an obesity-promoting diet.
    Picard F; Boivin A; Lalonde J; Deshaies Y
    Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E412-8. PubMed ID: 11788374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of feeding grape pomace on selected metabolic parameters associated with high fructose feeding in growing Sprague-Dawley rats.
    Khanal RC; Howard LR; Rogers TJ; Wilkes SE; Dhakal IB; Prior RL
    J Med Food; 2011 Dec; 14(12):1562-9. PubMed ID: 21861715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase-promoting agent, in STZ-induced diabetic rats.
    Tsutsumi K; Inoue Y; Shima A; Murase T
    Diabetes; 1995 Apr; 44(4):414-7. PubMed ID: 7698509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effect of Ibrolipim on suppressing lipid accumulation and increasing lipoprotein lipase in the kidneys of diet-induced diabetic minipigs.
    Liu Y; Wang ZB; Yin WD; Li QK; Cai MB; Yu J; Li HG; Zhang C; Zu XH
    Lipids Health Dis; 2011 Jul; 10():117. PubMed ID: 21762526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the lipoprotein lipase activator NO-1886 on adriamycin-induced nephrotic syndrome in rats.
    Nakayama K; Hara T; Kusunoki M; Tsutsumi K; Minami A; Okada K; Sakamoto S; Ohnaka M; Miyata T; Nakamura T; Aoki T; Fukatsu A; Nakaya Y; Kakumu S
    Metabolism; 2000 May; 49(5):588-93. PubMed ID: 10831167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dietary consumption of cranberry powder on metabolic parameters in growing rats fed high fructose diets.
    Khanal RC; Rogers TJ; Wilkes SE; Howard LR; Prior RL
    Food Funct; 2010 Oct; 1(1):116-23. PubMed ID: 21776462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lipoprotein lipase-promoting agent, NO-1886, improves glucose and lipid metabolism in high fat, high sucrose-fed New Zealand white rabbits.
    Yin W; Yuan Z; Tsutsumi K; Xie Y; Zhang Q; Wang Z; Fu G; Long G; Yang Y
    Int J Exp Diabesity Res; 2003; 4(1):27-34. PubMed ID: 12745668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.